Introduction to Glomerular Disease: Clinical Presentations

Comprehensive Clinical Nephrology: Fourth Edition

Volumn , Issue , 2010, Pages 193-207

  Floege, Jürgen ^a   Feehally, John ^b  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84878530046     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-05876-6.00015-0     Document Type: Chapter

References (27)

1. Iseki K, Iseki C, Ikemiya Y, Fukiyama K Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int 1996, 49:800-805.
2. Topham PS, Harper SJ, Furness PN, et al. Glomerular disease as a cause of isolated microscopic haematuria. Q J Med 1994, 87:329-336.
3. Springberg PD, Garrett LE, Thompson AL, et al. Fixed and reproducible orthostatic proteinuria. Results of a 20 year follow up study. Ann Intern Med 1982, 97:516-519.
4. Orth SR, Ritz E The nephrotic syndrome. N Engl J Med 1998, 338:1201-1212.
5. Cameron JS Nephrotic syndrome in the elderly. Semin Nephrol 1996, 16:319-329.
6. Haas M, Meehan SM, Karison TG, Spargo BH Changing etiologies of unexplained adult nephrotic syndrome: A comparison of renal biopsy findings from 1976-1979 and 1995-1997. Am J Kidney Dis 1997, 30:621-631.
7. Kaysen G, Gambertoglio J, Felts J, Hutchison F Albumin synthesis, albuminuria and hyperlipidemia in nephrotic syndrome. Kidney Int 1987, 31:1368-1376.
8. Humphreys MH Mechanisms and management of nephrotic edema. Kidney Int 1994, 45:266-281.
9. Svenningsen P, Bistrup C, Friis UG, et al. Plasmin in nephrotic urine activates the epithelial sodium channel. J Am Soc Nephrol 2009, 20:299-310.
10. Rodriguez-Iturbe B, Herrera-Acosta J, Johnson RJ Interstitial inflammation, sodium retention and the pathogenesis of nephrotic edema. Kidney Int 2002, 62:1379-1384.
11. Glassock RJ Prophylactic anticoagulation in nephrotic syndrome: A clinical conundrum. J Am Soc Nephrol 2007, 18:2221-2225.
12. Wheeler DC, Bernard DB Lipid abnormalities in nephrotic syndrome. Am J Kidney Dis 1994, 23:331-346.
13. Strippoli GFM, Navaneethan SD, Johnson DW, et al. Effects of statins in patients with chronic kidney disease: Meta-analysis and meta-regression of randomised controlled trials. BMJ 2008, 336:645-651.
14. Smith JD, Hayslett JP Reversible renal failure in the nephrotic syndrome. Am J Kidney Dis 1992, 19:201-213.
15. Jennette JC, Falk RJ Adult minimal change glomerulopathy with acute renal failure. Am J Kidney Dis 1990, 16:432-437.
16. Remuzzi G, Benigni A, Remuzzi A Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 2006, 116:288-296.
17. Wilmer WA, Rovin BH, Hebert CJ, et al. Management of glomerular proteinuria: A commentary. J Am Soc Nephrol 2003, 14:3217-3232.
18. Klahr S, Levey AS, Beck GJ, et al. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. N Engl J Med 1994, 330:877-884.
19. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003, 289:2560-2572.
20. Maschio G, Alberti D, Janin G, et al. Effect of the angiotensin-converting-enzyme inhibitor, benazepril, on the progression of chronic renal insufficiency. N Engl J Med 1996, 334:939-945.
21. The GISEN Group Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 1997, 349:1857-1863.
22. Jafar TH, Schmid CH, Landa M, et al. Angiotensin-converting enzyme inhibitors and progression of non-diabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med 2001, 135:73-87.
23. Mann JF, Schmieder RE, McQueen M, et al. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): A multicentre, randomised, double-blind, controlled trial. Lancet 2008, 372:547-553.
24. Maroni BJ, Staffield C, Young VR, et al. Mechanisms permitting nephrotic patients to achieve nitrogen equilibrium with a protein restricted diet. J Clin Invest 1997, 99:2479-2487.
25. Sarasin FP, Schifferli JA Prophylactic oral anticoagulation in nephrotic patients with idiopathic membranous nephropathy. Kidney Int 1994, 45:578-585.
26. Ogi M, Yokoyama H, Tomosui N, et al. Risk factors for infection and immunoglobulin replacement therapy in adult nephrotic syndrome. Am J Kidney Dis 1994, 24:427-436.
27. Talar-Williams C, Hijazi C, Walther M, et al. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener's granulomatosis. Ann Intern Med 1996, 124:477-484.